Prostate Cancer Research

He engaged in identifying good biomarkers for cancer and this led him to determine the role of secretory protein in prostate cancer, how they might contribute to metastasis. He also studied loss and gain of function using inducible strategy in the cell lines. The goal is to develop a mouse metastatic xeno-graft model in which he could see a tumor affecting the organ in which cancer could be studied. His research interests include the biological studies of Cancers especially Prostate, Nano Drug delivery and development of xenograft and Knock out animal models for understanding cancer progression. Moreover, he is also interested in CART cell therapy and Organ on Chips (OOCs). In addition, he does clinical trials for Prostametrix devices and understands the role of urinary biomarkers for early prostate cancer detection.

Team

Current Members

  • Mr. Jonathan Yeswanth Daniel, Research Scholar:
    Focuses on Nanomedicine for Prostate Cancer therapeutic.
  • Ms. Pranathi K, Master Student:
    Role of Nano Enzalutamide therapy for Castrated Resistance Metastatic Prostate Cancer.
  • Mr. Sathish K, Master Student:
    Nanomedicines and its toxicity profile on Zebrafish embryos.

We are currently looking for talented PhD students to expand our team in the areas of Nanomedicines, CAR-T, and Organ-on-Chip technologies.

Ongoing Projects

Current

  • Development of Elastin nanogels for Prostate Cancer Therapy:
    DST SERB funded (2022–2025).
  • Role of Urinary biomarkers for Prostate Cancer Detection:
    Medicametrix (2021 onwards).

Admissions